🚨 The final analysis of the phase 3 #ALEXANDRA/IMpassion030 study on adding atezolizumab to post-op chemo for high-risk early-stage #TNBC is out in @jama.com, contributing to a greater understanding of immunotherapy in #breastcancer👉 jamanetwork.com/journals/jam... @mignatiadis.bsky.social

The results of SONIA are out on @Nature. 1L use of palbo did not improve PFS over 2L use, but led to more AEs & costs. An evolving treatment landscape challenges its interpretation— yet it shows that sequencing trials are possible. Congrats to the authors! www.nature.com/articles/s41...

Like ‘old Twitter’: The scientific community finds a new home on Bluesky After recent changes to Elon Musk’s X, a gradual migration turns into a stampede www.science.org/content/arti...

Institut Jules Bordet (part of the) medical oncology team dinner 🤗 @mignatiadis.bsky.social is already here 🦋 and we are lobbying for others to migrate!